Andrew Fishleder, M.D. Has A Thirty-Year History With Cleveland Clinic.
Cleveland Clinic (USA) and Mubadala Healthcare (Abu Dhabi) have appointed Andrew Fishleder, M.D. to hold the position of Chief Executive Officer of Cleveland Clinic Abu Dhabi.
Scheduled to open in 2011, the 360-bed multi-specialty hospital will be a unique and unparalleled extension of the Cleveland Clinic model. The hospital is a vital part of Mubadala Healthcare’s strategy to build an integrated healthcare delivery network.
Dr. Fishleder assumed responsibility for the overall operations of Cleveland Clinic Abu Dhabi on January 1, 2009.
As construction is currently underway, he is focusing on the implementation of the systems, procedures, guidelines and standards for the hospital as an extension of Cleveland Clinic’s model of medicine and clinical capabilities in the Middle East.
“I am truly honored to have the opportunity to lead Cleveland Clinic’s expansion in the Middle East and to partner with the dedicated leadership of Mubadala Healthcare,” Dr. Fishleder said. “I am confident that my years of experience as a physician executive at Cleveland Clinic and collaborative leadership style will allow me to contribute to the success of this exciting project.”
Dr. Fishleder was instrumental in the development of Cleveland Clinic’s Education Institute, which he recently led as its Chairman. In addition, Dr. Fishleder served as Executive Dean of the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Beginning his medical career as a pathologist at Cleveland Clinic in 1978, he has held various leadership and executive positions, and serves as a member of the Cleveland Clinic’s Board of Governors and has been a member of the institution’s Medical Executive Committee since 1991.
“Over the last 30 years, Dr. Fishleder has been an integral part of the success and expansion of Cleveland Clinic,” said Delos M. “Toby” Cosgrove, M.D., CEO and President of Cleveland Clinic. “We are very confident that Dr. Fishleder’s proven leadership and vision will continue the Cleveland Clinic and Mubadala Development’s mission to deliver the highest quality healthcare to the Middle East region.”
“We are delighted to welcome Dr. Fishleder,” said Mubadala Healthcare’s Executive Director, Mark Erhart. “His leadership and specific expertise will ensure that Cleveland Clinic Abu Dhabi provides the highest international standards of care and superior clinical outcomes for patients in Abu Dhabi and the UAE.”
In addition to Dr. Fishleder’s appointment, Cleveland Clinic and Mubadala Healthcare are excited to announce Rob Lorenz, M.D. as Chief Medical Officer at Cleveland Clinic Abu Dhabi. Most recently, Dr. Lorenz was the Section Head of Head and Neck Surgery in the Head and Neck Institute at Cleveland Clinic (US).